News

For press please email comms@vatic.health
March 16, 2022
“Vatic COVID-19 Home Spike Test” OTC EUA Submitted to FDA
MARCH 16, 2022 - Vatic Health Limited (https://www.vatic.health/usa) today announces that it has submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for a non-prescription Over The Counter (OTC) Vatic COVID-19 Home Spike Test
Read moreRead more
Had COVID - 19 symptoms in the last 2 days? Apply here to help us make testing accessible to all.
Close Cookie Popup
Cookie Settings
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
Accept All Cookies
Cookie Settings
Made by Flinch 77
Cookies Preferences
Close Cookie Preference Manager
Cookie Settings
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
Strictly Necessary (Always Active)
Cookies required to enable basic website functionality.
Accept All Cookies
Save Settings
Made by Flinch 77
Oops! Something went wrong while submitting the form.

Our Vatic COVID-19 SpikeTest is not available for sale in the United States (USA).
It is currently for investigational use only and has been submitted for EUA.

Vatic Health Inc
Registered office:
Corporation Trust Centre, 2109 Orange Street,
Wilmington, County of Newcastle,
Delaware 19808.
The name of the Corporation's registered agent at such address is The Corporation Trust Company

Privacy policy
‍